GEXVal Receives FDA Orphan Drug Designation for GXV-001 in Fragile X Syndrome
2025年11月19日
株式会社GEXValNovember 19, 2025 GEXVal Receives FDA Orphan Drug Designation for GXV-001 in Fragile X Syndrome GEXV […]
GEXVal CEO to Speak at China Healthcare Summit 2025
2025年10月20日
株式会社GEXValOctober 20, 2025 GEXVal CEO Invited and to Speak at BioCentury-BayHelix China Healthcare Summit 20 […]
GEXVal CTO to Present at CBI Annual Meeting 2025
2025年10月17日
株式会社GEXValOctober 17, 2025 GEXVal CTO to Present at Chemo-Bio Informatics Society (CBI) Annual Meeting 2025 […]
GEXVal to Exhibit at BioJapan 2025
2025年10月3日
株式会社GEXValOctober 3, 2025 GEXVal to Showcase AI-Powered Drug Discovery Platform RePhaIND® at BioJapan 2025 […]